Growing up in the suburbs of New York in the 1970s, as one of us (IO) did, was not necessarily a good time to fall in love with the city. It was a time of historic blackouts, the Son of Sam, and the infamous Daily News headline FORD TO CITY: DROP DEAD. But it was also a decade during which the Yankees went back to the World Series, and the city began rebounding. In many ways, it hasn't looked back.
The life sciences industry's relationship with New York is more complicated, even the reverse. Things tend to start well. The city's 25 biomedical institutions and 147 hospitals get more than $1 billion in funding from the NIH annually, and the area's institutions have been granted more biotechnology patents than any other region. Some of the graduates and faculty of those institutions create an average of 30 biotech startups per year....
While responsibility for the content rests solely with the editors, we gratefully acknowledge the following group of advisors, who provided much advice and support on this supplement.
Keith Brownlie, Metro New York Area Emerging & Growth Markets Life Science Industry Leader, Ernst and Young
Ron Cohen MD, President and CEO, Acorda
Daniel Devine, CEO, Acceptys
Karen A. Duncker, Executive Director, New York Biotech Association
William R. Fair III, Vice President, New York City Economic Development Council
Joseph M. Feczko MD, Vice President, Pfizer Inc and President, Worldwide Development, Pfizer
Maria G. Gotsch, Senior Vice President, New York City Investment Fund
Eileen Hilton MD, President and CEO, BRANY
Jane M. Love PhD, Counsel/Junior Partner, Wilmer Cuttler Pickering Hale and Dorr
Daniel C. Lubin, Managing Partner, Radius Ventures
Matthew McCooe, Director, New Ventures, Columbia University Science and Technology Ventures
Ellis Rubinstein, President, New York Academy of Sciences
Joanna Rubinstein PhD, DDS, Senior Associate Dean for International and Global Initiatives, Columbia University Medical Center
Tim Wright PhD, Senior Member, Research Division, Hospital for Special Surgery and Professor at Weill Medical College
Gary Zammit PhD, President and CEO, Clinilabs
SPECIAL THANKS TO:
Bill Fair and Monique Salazar of the New York City Economic Development Corporation, for providing background information, making introductions, and other invaluable assistance.